Table 5
Predicted relative excess risks (RERs) of death for women compared with men, by cancer and follow-up interval, ages 15 to 99, Canada excluding Quebec, 2004-to-2008 periodNote †

Table 5
Predicted relative excess risks (RERs) of death for women compared with men, by cancer and follow-up interval, ages 15 to 99, Canada excluding Quebec, 2004-to-2008 period†
Table summary
This table displays the results of Predicted relative excess risks (RERs) of death for women compared with men. The information is grouped by Cancer (appearing as row headers), Follow-up interval (years), 0 to 1, 1 to 3, 3 to 5, RER and 95% confidence interval, calculated using from and to units of measure (appearing as column headers).
Cancer Follow-up interval (years)
0 to 1 1 to 3 3 to 5
RER 95% confidence interval RER 95% confidence interval RER 95% confidence interval
from to from to from to
All cancersNote ‡ 0.92 0.91 0.93 0.86 0.84 0.88 0.85 0.81 0.89
Oral cavity and pharynx 0.83 0.75 0.91 0.79 0.70 0.89 0.72 0.57 0.91
Esophagus 0.98 0.90 1.05 0.78 0.67 0.91 0.94 0.62 1.41
Stomach 1.01 0.96 1.07 0.80 0.72 0.88 0.77 0.59 1.00
Colon 1.01 0.97 1.05 0.95 0.89 1.01 0.81 0.72 0.91
Rectum 0.93 0.86 1.00 0.88 0.81 0.96 0.82 0.72 0.94
Liver 0.93 0.85 1.02 1.07 0.90 1.28 0.86 0.58 1.25
Pancreas 0.91 0.87 0.95 0.93 0.84 1.03 0.75 0.55 1.03
Larynx 1.01 0.79 1.28 0.92 0.71 1.21 1.22 0.83 1.80
Lung and bronchus 0.81 0.80 0.83 0.81 0.78 0.84 0.92 0.84 1.00
Skin melanoma 0.49 0.40 0.61 0.55 0.46 0.65 0.48 0.36 0.64
Bladder (including in situ) 1.47 1.36 1.60 1.04 0.92 1.18 0.94 0.74 1.21
Kidney and renal pelvis 0.93 0.86 1.00 0.77 0.67 0.88 0.92 0.73 1.15
Brain and other nervous system 0.95 0.90 1.01 0.72 0.65 0.80 0.80 0.63 1.01
Thyroid 0.43 0.32 0.57 0.23 0.09 0.60 Note ..: not available for a specific reference period Note ..: not available for a specific reference period Note ..: not available for a specific reference period
Hodgkin lymphoma 0.56 0.43 0.73 0.87 0.60 1.27 0.74 0.43 1.27
Non-Hodgkin lymphoma 0.86 0.81 0.91 0.76 0.69 0.85 0.76 0.65 0.88
Multiple myeloma 0.92 0.84 1.01 1.00 0.89 1.12 1.03 0.87 1.22
Leukemia 1.10 1.04 1.17 0.88 0.77 1.00 0.69 0.56 0.87
OtherNote ‡ and unknown 1.01 0.98 1.04 0.97 0.91 1.03 0.94 0.84 1.06
.. data not available (model did not converge)
Note †

period method of survival analysis used

Return to note † referrer

Note ‡

excluding genital system cancers and breast cancer

Return to note ‡ referrer

Notes: All results were adjusted for age group. All cancers were also adjusted for case mix.
Sources: Canadian Cancer Registry database; life tables; Canadian Vital Statistics Death database.

More information

ISSN: 1209-1367

Note of appreciation

Canada owes the success of its statistical system to a long-standing partnership between Statistics Canada, the citizens of Canada, its businesses, governments and other institutions. Accurate and timely statistical information could not be produced without their continued co-operation and goodwill.

Standards of service to the public

Statistics Canada is committed to serving its clients in a prompt, reliable and courteous manner. To this end, the Agency has developed standards of service which its employees observe in serving its clients.

Copyright

Published by authority of the Minister responsible for Statistics Canada.

© 2016 Minister of Industry

Use of this publication is governed by the Statistics Canada Open Licence Agreement.

Catalogue no. 82-003-X

Frequency: Monthly

Ottawa

close
Date modified: